YTHDF2 and central nervous system cancer: Unfortunately, no data were available on YTHDF2 expression in adjacent normal tissues for the following cancers: adrenocortical carcinoma, DLBC (lymphoid neoplasm diffuse large B-cell lymphoma), GBM (glioblastoma multiforme), LAML (acute myeloid leukemia), LGG (lower-grade glioma), mesothelioma, OV (ovarian serous cystadenocarcinoma), PAAD (pancreatic adenocarcinoma), pheochromocytoma and paraganglioma, SARC (sarcoma), skin cutaneous melanoma, testicular germ cell tumor, thymoma, uterine carcinosarcoma, and uveal melanoma.